细菌细胞外囊泡:在肝脏疾病中,肠肝轴交叉的新兴媒介
Yutong Zhou1, Yong Sun1, Pengsheng Yin1
1Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Frontiers in cellular and infection microbiology
|July 7, 2025
概括
细菌细胞外囊泡 (BEVs) 在肠肝轴中至关重要,影响肝脏疾病. 研究探讨了它们在疾病进展中的作用以及诊断和治疗的潜力.
科学领域:
- 微生物学 微生物学
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
背景情况:
- 细菌细胞外囊泡 (BEVs) 介导肠肝轴通信.
- BEVs携带病原性因素,如LPS,导致肝脏代谢功能障碍和疾病.
研究的目的:
- 系统地审查BEV的生产,分类和肝脏疾病中的监管作用.
- 探索BEVs在肝脏疾病中的双重诊断和治疗潜力.
主要方法:
- 对肝病中的BEV机制的文献进行系统审查.
- 对参与BEV诱导的肝病理的信号通路 (LPS/TLR4,cGAS/STING,TGF-β) 的分析.
主要成果:
- BEVs通过致病因子和信号通路促进MAFLD,纤维化和HCC.
- BEV具有作为非侵入性生物标志物和治疗剂的潜力,包括工程和益生菌形式.
结论:
- BEVs是肝病病原体的重要参与者,为诊断和精准医学提供了机会.
- 挑战包括BEV异质性,隔离性,稳定性和临床翻译性,需要进一步的研究和多学科方法.
相关概念视频
Overview of Exosomes
2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
Hepatic Drug Excretion: Enterohepatic Cycling
1.8K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.8K
Hepatic Drug Clearance: Role of Transporters
105
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
105
Hepatic Drug Excretion: Influencing Factors
231
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
231
Diseases of the Liver and Gallbladder
1.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.0K
Intralumenal Vesicles and Multivesicular Bodies
3.7K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.7K


